» Articles » PMID: 15228413

Role of Surgical Resection for Lung, Liver, and Central Nervous System Metastases in Patients with Gynecological Cancer: a Literature Review

Overview
Date 2004 Jul 2
PMID 15228413
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Many reports of ovarian, cervical, and uterine cancers metastatic to lung, liver, and brain have been published. A fewer number of them focused on the surgical treatment for these patients. We reviewed the published literature, regarding surgical management of metastatic disease in patients with gynecological cancer. Some prognostic factors in the patients with metastatic lesions from these three different cancers were found in common. Favorable prognostic factors for a prolonged survival were good performance status of the patients, long disease-free interval, absence of other systemic disease, and the resectability, preferably with a clear margin. These factors should be considered as the criteria for surgery. In well-selected patients, survival could be extended from the surgical procedure with minimal complications. Other types of treatment such as radiation therapy or chemotherapy could also be given in conjunction with surgery, depending on tumor type and disease status of the primary cancer, other systemic diseases, and residual metastatic lesions after surgery.

Citing Articles

Range of Resection in Endometrial Cancer-Clinical Issues of Made-to-Measure Surgery.

Horala A, Szubert S, Nowak-Markwitz E Cancers (Basel). 2024; 16(10).

PMID: 38791927 PMC: 11120042. DOI: 10.3390/cancers16101848.


Reassessment of intensive surveillance practices adopted for endometrial cancer survivors.

Nakamura K, Kitahara Y, Yamashita S, Kigure K, Ito I, Nishimura T BMC Womens Health. 2022; 22(1):355.

PMID: 35999573 PMC: 9396785. DOI: 10.1186/s12905-022-01937-1.


Salvage Treatment and Outcomes of Locally Advanced Cervical Cancer after Failed Concurrent Chemoradiation with or without Adjuvant Chemotherapy: Post Hoc Data Analysis from the ACTLACC Trial.

Asakij T, Khunnarong J, Tangjitgamol S, Rongsriyam K, Tharavichitkul E, Tovanabutra C Asian Pac J Cancer Prev. 2022; 23(7):2263-2269.

PMID: 35901330 PMC: 9727368. DOI: 10.31557/APJCP.2022.23.7.2263.


Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer.

Wu J, Zhang L, Wu S, Liu Z Front Mol Biosci. 2022; 9:929832.

PMID: 35847989 PMC: 9284435. DOI: 10.3389/fmolb.2022.929832.


Recurrent Endometrial Cancer: Local and Systemic Treatment Options.

Rutten H, Verhoef C, Van Weelden W, Smits A, Dhanis J, Ottevanger N Cancers (Basel). 2021; 13(24).

PMID: 34944893 PMC: 8699325. DOI: 10.3390/cancers13246275.